Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant.

Journal of hepatology - 1 May 2000

Yeh C T, Sheen I S, Chen T C, Hsieh S Y, Chu C M, Liaw Y F

Abstract excerpt

BACKGROUND/AIMS: The aim of this study was to understand the changes in the proportion of hepatitis B virus precore stop mutant during the course of prednisolone primed interferon (IFN) therapy. METHODS: Three groups of patients were included: patients receiving prednisolone-primed IFN treatment (Group I, n=31), IFN treatment only (Group II, n=29), and placebo (Group III, n=25). The proportion of precore stop...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Anti-Inflammatory Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Interferons

Share to Prednisolone

Share to Viral Core Proteins

Source

Identifiers

PMID: 10845671
DOI: 10.1016/s0168-8278(00)80253-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant.PMID 10845671Read ↗

Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon.Semantic proximity Read ↗

Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon.Semantic proximity Read ↗

Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C.Semantic proximity Read ↗

Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine.Semantic proximity Read ↗

A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C.Semantic proximity Read ↗

Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.Semantic proximity Read ↗

Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.Semantic proximity Read ↗

Interferonopathies: From concept to clinical practiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.